Heart medtech Anteris raises $39m to fund clinical strategy
SYDNEY: Anteris Technologies, a dual-listed heart medtech backed by L1 Capital and New York healthcare-focused
SYDNEY: Anteris Technologies, a dual-listed heart medtech backed by L1 Capital and New York healthcare-focused